Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Clinical trial NCT07040982 · RECRUITING
Trial details
- NCT number
- NCT07040982
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-19
- Primary completion
- 2028-06-13
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.